Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis

Rheumatoid arthritis is the most prevalent systemic autoimmune disease among the rheumatic inflammatory musculoskeletal diseases. Currently, there is no reliable evidence regarding the comparisons of anti-rheumatic effects between leflunomide and Janus kinase inhibitors. We performed a protocol for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaogang, Zhang, Mingming, Wang, Zhiqiang, Liu, Yanqing, Feng, Xing, Yang, Liu, Wang, Yajing, Liu, Juan, Zhao, Dongbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750582/
https://www.ncbi.nlm.nih.gov/pubmed/36626515
http://dx.doi.org/10.1097/MD.0000000000032154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750582/
https://www.ncbi.nlm.nih.gov/pubmed/36626515
http://dx.doi.org/10.1097/MD.0000000000032154

Ejemplares similares